SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001356576-23-000056
Filing Date
2023-08-21
Accepted
2023-08-21 09:05:29
Documents
14
Period of Report
2023-08-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K supn-20230817.htm   iXBRL 8-K 29998
2 EX-99.1 ex99108-21x2023.htm EX-99.1 12978
6 supernuslogo.jpg GRAPHIC 19991
  Complete submission text file 0001356576-23-000056.txt   201231

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20230817.xsd EX-101.SCH 1917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20230817_lab.xml EX-101.LAB 24138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20230817_pre.xml EX-101.PRE 12522
8 EXTRACTED XBRL INSTANCE DOCUMENT supn-20230817_htm.xml XML 2727
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35518 | Film No.: 231187459
SIC: 2834 Pharmaceutical Preparations